Materials and Methods

Study Design
The present case-control study was performed from the first of June 2016 to the 30th of May 2017 in the Obstetrics and Gynecology Department of Baghdad University at Baghdad teaching hospital/medical city complex. One hundred pregnant women in the first trimester of pregnancy were included in this study. After clinical and ultrasonic findings, they were divided into 2 groups including those with unruptured EP (50 cases) and normal intrauterine pregnancy (50 controls).
Data Collection Socio-demographic information was collected about age, gestational age (GA), obstetrical history, past medical and surgical history, and previous mode of delivery. In addition, trans-abdominal ultrasound was performed by ultrasound machine (Philips HD 11XE) using the curvilinear probe (frequency 2-5MHZ).
Laboratory Analysis
To this end, 5 mL of blood was taken from the patient and control groups to measure the serum GD and then the serum was separated and stored at -20°C or -80°C after centrifugation for 15 minutes. Finally, the sera were assayed using the human GD Elisa kit (catalog number. SB-E12071h) for the quantitative determination of human GD concentration in the serum.
Statistical Analysis
Independent t test and chi-square test were used for the statistical inference between EP and intrauterine pregnancy (IUP) groups. Additionally, receiver operator curve analysis was utilized to determine the area under the curve, the cut-off, and its validity. All analyses were performed using SPSS 21.0 software (Chicago, IL) and P < 0.05 was considered statistically significant. parity, miscarriage, past medical and surgical history, and previous mode of delivery while GA was significantly lower in an EP (Table 1) .
Similarly, GD levels in EP were significantly lower than those with normal IUP (1.58 ± 1.18 vs. 30.1 ± 11.9) ,and these lower levels were maintained in different GAs (i.e., 6 th , 7 th , and 8 th weeks). The results further revealed that in EP, an increased in GA led to a decrease in GD levels while in normal pregnancy, GD levels increased with an increase in GA ( Table 2 and Figure 1 ).
Moreover, receiver operator characteristic analysis was performed to assess the validity of GD as the predictor of EP. Eventually, GD was found to be an excellent predictor of EP with an optimal cut point of <9.5 ng/mL for predicting EP with 100% sensitivity, 100% specificity, 95% positive predictive value, 100% negative predictive value, and 100% accuracy ( Table 3 ).
Discussion
EP is still regarded as one of the important causes of maternal death worldwide although mortality has simultaneously declined from 35 deaths/10 000 EPs in 1970 to 4 deaths/10 000 EPs in 1985 (5) . In the United Kingdom, the number of ectopics and deaths has been fixed in the last 12 years with the mortality rate at 4 per 10 000 maternal pregnancies (6) .
In the current study, serum GD (previously named Abbreviation: SD, standard deviation. as placental protein 14 ) was significantly lower in EP compared to normal pregnancy ( 1.58 ± 1.18 vs. 30.1 ± 11.9 ng/mL, respectively) these findings were consistent through sixth, seventh, and eighth of pregnancy. Further analysis using the receiver operator curve demonstrated that test serum GD at the cut-off of ≤9.5 ng/mL had an excellent ability to predict EP with 100% sensitivity and 100% specificity, which is in agreement with the findings of Pedersen and Ruge (7) . The results of another study showed that the GD level was low (<5th percentile of the reference range of GD) in 81% of women with EP (8) . In addition, several other studies reported similar findings such as Ruge et al (9) and Foth & Römer who studied 169 women in their first trimester and found that GD serum level was significantly lower compared to normal pregnancy and those with incomplete abortion (10) . In a more recent study that examined multiple markers for predicting EP in the first trimester, GD was reported as the best individual marker of extra-uterine location (AUC 0.61) and further analysis at the cut-pint of ≤1.39 ng/ mL GD had higher sensitivity to predict EP; this study showed the clear role of GD as a screening marker for EP, especially when incorporated with other biomarkers (11) . The findings of all these studies are in line with the results of the current study, indicating that serum GD was significantly lower in EP compared to normal pregnancy.
In the current study, GD levels had an inverse relationship with GA, namely, it decreased with advanced GA ( 3.03 ± 1.3, 1.21 ± 0.9, and 0.34 ± 0.16 from sixth to eighth weeks of GA) while the relationship was direct between GA and GD levels in a normal pregnancy. Foth and Römer (10) revealed that the level of GD decreases with increasing GA in the first trimester of the ectopic patients, which corroborates with the findings of the present study.
Currently, no single biomarker for EP has yielded sufficient diagnostic accuracy and good reproducible results. Generally speaking, the makers of normal trophoblast and decidual function are usually lower in EP compared to normal IUP (12) . In a normal pregnancy, the GD level increases as pregnancy progresses until 8-10 weeks of gestation; this can be attributed to the hormonal effect in this period of pregnancy, a procedure which is done by the corpus luteum (13) . In ectopic pregnancies, the low GD levels might be a consequence of abnormalities in the functions of the corpus luteum (14) .
Limitation of the Study
Small sample size within a short period of the study, singlecenter for research, the absence of temporal relationship, and selection bias were among the limitations of the current study.
Conclusions
Overall, the serum level of GD significantly decreased in the first trimester of EP while in normal pregnancy, it steadily increased the validity results of GD (i.e., 100% sensitivity, 100% specificity, 95% positive predictive value, 100% negative predictive value, and accuracy 100%) in the prediction of EP at the cut point of 9.5 ng/mL.
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